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Abstract
Background: South Africa has an estimated 1.5 million persons in need of antiretroviral therapy (ART). In 2004, the
South African government began collaborating with the United States President’s Emergency Plan for AIDS Relief
(PEPFAR) to increase access to ART. We determined how PEPFAR treatment support changed from 2005-2009.
Methods: In order to describe the change in number and type of PEPFAR-supported ART facilities, we analyzed
routinely collected program-monitoring data from 2005-2009. The collected data included the number, type and
province of facilities as well as the number of patients receiving ART at each facility.
Results: The number of PEPFAR-supported facilities providing ART increased from 184 facilities in 2005 to 1,469
facilities in 2009. From 2005-2009 the number of PEPFAR-supported government facilities increased 10.1 fold from
54 to 546 while the number of PEPFAR-supported NGO facilities (including general practitioner and NGO facilities)
increased 6.2 fold from 114 to 708. In 2009 the total number of persons treated at PEPFAR-supported NGO facilities
was 43,577 versus 501,089 persons at PEPFAR-supported government facilities. Overall, the median number of
patients receiving ART per site increased from 81 in 2005 to 136 in 2009.
Conclusions: To mitigate the gap between those needing and those receiving ART, more facilities were
supported. The proportion of government facilities supported and the median number of persons treated at these
facilities increased. This shift could potentially be sustainable as government sites reach more individuals and
receive government funding. These results demonstrate that PEPFAR was able to support a massive scale-up of
ART services in a short period of time.
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Background
South Africa has the highest number of HIV infected
individuals, and one of the highest prevalences of HIV
infection in the world. In 2005 an estimated 4.7 million
persons were HIV infected and only approximately
123,000 were receiving treatment [1]. In 2004, the South
African government (SAG) began collaborating with the
United States President’s Emergency Plan for AIDS
Relief (PEPFAR) to increase access to antiretroviral ther-
apy, as well as other HIV care and prevention services.
PEPFAR support was provided through the development
of policies and guidelines and the provision of training,
drugs, laboratory services, staff, equipment and technical
assistance. By 2010 the U.S. government, through PEP-
FAR, had contributed over 2.4 billion U.S. dollars to
address HIV/AIDS and tuberculosis in South Africa [2].
Effective scale-up of antiretroviral therapy delivery
requires host country leadership and coordination
between donors, implementing partners and host coun-
try governments. The initial emergency phase of PEP-
FAR implementation from 2004-2009 was through
implementing partners, primarily non-governmental
international, and local organizations, with the goal of
rapidly increasing access to treatment to those most in
need [3]. These non-governmental organizations work
both in private and public sites, however, the SAG
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any medium, provided the original work is properly cited.directed these early services toward public hospitals and
large public clinics in order to quickly treat the largest
and most accessible patient populations [4].
Facilities supported by PEPFAR can be broadly cate-
gorized as: public sector sites, non-governmental organi-
zation (NGO) sites, and general practitioner (GP)
networks. In these facilities, PEPFAR implementing part-
ners provide a range of support depending on the needs
of the facility. All facilities that are counted in this
review have PEPFAR-supported activities that are
directly connected to service delivery at that site [5]. In
public facilities, this support can include a combination
of staff, equipment, training, information management
and other activities. Support at non-governmental sites
largely focused on service delivery through existing
infrastructure managed by faith-based organizations.
Support for GP networks included providing ART
access to persons who were in the queue at public facil-
ities or were uninsured or underinsured teachers or
union workers. This report describes how PEPFAR sup-
port evolved at the treatment delivery (facility) level
from October 2005 through September 2009.
Methods
Since 2005 all PEPFAR implementing partners funded to
support antiretroviral therapy have submitted quarterly
monitoring data through a web-based system (MySQL,
MySQL AB, Uppsala, Sweden) [6]. From October 2005
through September 2009 the reported indicators
included persons currently on antiretroviral therapy,
facilities providing antiretroviral therapy, the type of
facility providing antiretroviral therapy (government,
NGO, and private), and the province in which the facil-
ity operates. NGO partners may provide support to gov-
ernment facilities. Where data on management type and
facility were missing, we contacted the projects’ man-
agers to complete the data. Twenty partners reported
aggregate data for at least some of the facilities (for
example one partner aggregated all the private general
practitioner facilities) therefore not allowing us to deter-
mine location for that specific facility.
Some partners reported facilities as providing antire-
troviral therapy, but then reported zero persons on anti-
retroviral therapy for that facility. We report the
number of facilities in that category, but removed them
from all analyses of facility size. For the reported aggre-
gate data, the average facility size was determined by
calculating the number of persons on treatment divided
by the number of facilities. In instances where the quar-
terly report for a facility reported patients on treatment,
but not the number of facilities, we recorded it as one
facility (n = 42 facilities in 2005; n = 32 facilities in
2009).
We conducted a retrospective review of routinely col-
lected PEPFAR monitoring data from September 2005
to October 2009. We describe the PEPFAR-supported
sites by year, management type, location, and number of
persons currently on treatment (reporting medians and
ranges.) We describe the rate of change in number of
facilities.
Results
The number of PEPFAR-supported facilities providing
antiretroviral therapy increased from 184 facilities in
2005 to 1,469 facilities in 2009, an average increase of
132.3 facilities each year. The median number of
patients receiving antiretroviral therapy per site
increased from 81 patients (range 3 to 1,584) in 2005 to
136 patients (range 1 to 8,656) in 2009. From 2005 to
2009 the number of non-government facilities (including
private general practitioner and NGO facilities)
increased 6.2 fold from 114 to 708 while the number of
PEPFAR-supported government facilities increased 10.1
fold from 54 to 546 (management type was not recorded
for 16 facilities in 2005 and 215 in 2009.) The number
of persons treated at these facilities is shown in Table 1.
There was a shift in the distribution of facilities by
province from 2005 to 2009 (Figure 1.) When the distri-
bution of facilities is standardized by the number of per-
sons living with HIV, this shift is still apparent (Figure
2.) In 2005 there were 3.4 times as many PEPFAR-sup-
ported facilities in Gauteng as in any other province. In
2009 the province with the most PEPFAR-supported
facilities was KwaZulu-Natal with 351 facilities, followed
by Gauteng and Eastern Cape with 329 and 202 PEP-
FAR-supported facilities, respectively. Northern Cape
had the fewest facilities with only 10.
In 2005 107 sites reported providing antiretroviral
therapy services, but no persons currently on treatment
versus only 28 such sites in 2009.
Discussion
Through our analysis of routinely collected PEPFAR
monitoring data we found that in order to support the
provision of antiretroviral treatment to a increasing
number of people in need in South Africa, new govern-
mental and nongovernmental facilities were rapidly
capacitated to provide treatment. Despite health system
constraints and the SAG’s initial reluctance to show full
support for a national ART program, [7,8] the propor-
tion of government facilities supported increased drama-
tically, as did the number of persons treated at
governmental facilities.
The flexibility of PEPFAR to partner with both the
private and public sector allowed for an initial engage-
ment with the private sector, as it was equipped to assist
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Page 2 of 5in a quick roll-out of access to ART, followed by a tran-
sition to supporting a larger proportion of governmental
facilities. Because governmental sites reach more indivi-
duals and are supported by the South African govern-
ment scale-up of ART, supporting governmental sites
may have a larger impact and be more sustainable. Flex-
ibility in the scale-up of supported facilities allowed for
this shift in the proportion of PEPFAR-supported sites
with recorded management type from 32% public in
2005 to 44% public in 2009. While there were over 700
non-governmental facilities supported, about 65% were
general practitioner sites with fewer than 10 patients.
Additionally, the increase in number of persons treated
at governmental sites indicates not only a PEPFAR ART
scale-up, but also reflects the SAG’s expanded commit-
ment to universal access to treatment. The reduction in
the median number of patients per facility in private
facilities may indicate that as services become available
in public facilities, people are less reliant on private
facilities for treatment. Our findings are consistent with
previous estimations of the number of persons on treat-
ment by facility type, which showed that beginning in
2005 more people were on treatment through public
sector sites than NGO or private and also that the
increase in persons on treatment was more rapid in the
public sector than non-governmental or private [9].
From 2005 to 2009 the geographic distribution of
facilities continued to be focused in areas with high
numbers of persons living with HIV, but also shifted to
increase coverage across all provinces, suggesting a
move toward deliberate scale up [2]. KwaZulu-Natal is
t h ep r o v i n c ew i t ht h el a r g e s t number of persons living
with HIV (approximately 1,489,972 persons in 2009),
followed by Gauteng and Eastern Cape (approximately
1,132,901 and 674,420 persons respectively in 2009)
[10,11].
The number of facilities may have been underesti-
mated, as some implementing organizations did not
report the number of facilities. However, most of these
reports were hospitals, not clusters of facilities, indicat-
ing that they were indeed only one facility. Because
almost one third of patients on treatment were reported
from partners with aggregated facilities, the median size
of the facilities may be skewed. In addition, the reduc-
tion over time in the number of facilities reporting that
they provide treatment services, but not reporting
Table 1 The total number of persons treated at PEPFAR-supported facilities: October 2005, September 2009
2005 2009
Total Facilities Total Persons Median patients per
facility (Range)
Total Facilities Total Persons Median patients per
facility (Range)
Non-governmental 114 9,732 29 (3 - 797) 708 43,577 3 (1 - 4,112)
NGO 30 6,333 138 (27 - 797) 94 34,299 81 (1 - 631)
Private 84 3,399 13 (3 - 481) 614 9,278 3 (5 - 4,112)
Governmental 54 41,460 441 (25 - 4,332) 546 501,089 488 (4 - 8,656)
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Figure 1 Distribution of PEPFAR-supported facilities in South Africa, by province October 2005, September 2009.
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Page 3 of 5persons currently on treatment, suggests an improve-
ment in the quality of reporting.
The rapid scale-up of access to ART was a “game
changer” in the fight against HIV & AIDS [12]. Treat-
ment coverage has greatly increased, and was estimated
to be about 85% in 2010 [1]. To continue providing
assistance toward increasing coverage and maintaining
treatment for many years to come, next steps will
involve making the transition from an emergency
oriented program to one that is focused on sustainabil-
ity, on achieving cost efficiencies, and on full alignment
with the SAG priorities and systems [13]. This will
include transitioning from international to local imple-
menting partners and increasing support for the SAG.
PEPFAR technical assistance will increasingly emphasize
health system strengthening, capacity development,
quality of care, as well as innovative strategies such as
nurse initiated and managed ART to provide sustain-
able, long-term access to care.
Conclusions
With the delivery of health services occurring so fre-
quently as a collaboration between donors, implement-
ing organizations and governments it is essential that
donors and implementing organizations be able to shift
their support to meet the needs of host-country govern-
ments considering the epidemiology of the epidemic
and current infrastructure.T h eS o u t hA f r i c a ng o v e r n -
ment has greatly increased access to ART, mitigating
the gap and promoting more equality Our analysis
demonstrates that in order to support this effort, PEP-
FAR rapidly increased the number of facilities
supported, particularly in areas with the highest preva-
lence of HIV.
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